Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 19, Issue 12, Pages 2865-2873
Publisher
Wiley
Online
2015-09-29
DOI
10.1111/jcmm.12679
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of complement proteins as screening markers for colorectal cancer
- (2014) Line Storm et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses
- (2014) Ole E. Sørensen et al. JOURNAL OF CLINICAL INVESTIGATION
- Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling
- (2014) Meike de Wit et al. Journal of Proteomics
- In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers
- (2014) George S. Karagiannis et al. Journal of Proteomics
- Robust Cre-Mediated Recombination in Small Intestinal Stem Cells Utilizing the Olfm4 Locus
- (2014) Jurian Schuijers et al. Stem Cell Reports
- Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease
- (2013) Wenli Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- The Human Neutrophil Subsets Defined by the Presence or Absence of OLFM4 Both Transmigrate into Tissue In Vivo and Give Rise to Distinct NETs In Vitro
- (2013) Amanda Welin et al. PLoS One
- Olfactomedin 4 Inhibits Cathepsin C-Mediated Protease Activities, Thereby Modulating Neutrophil Killing of Staphylococcus aureus and Escherichia coli in Mice
- (2012) W. Liu et al. JOURNAL OF IMMUNOLOGY
- Olfactomedin 4 suppresses tumor growth and metastasis of mouse melanoma cells through downregulation of integrin and MMP genes
- (2012) Key Sun Park et al. MOLECULES AND CELLS
- Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1
- (2011) Ling Chen et al. CARCINOGENESIS
- Alpha-1-antitrypsin is produced by human neutrophil granulocytes and their precursors and liberated during granule exocytosis
- (2011) Stine N. Clemmensen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD
- (2011) Michael Gersemann et al. Journal of Crohns & Colitis
- Olfactomedin 4 defines a subset of human neutrophils
- (2011) Stine N. Clemmensen et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Olfactomedin-4 Regulation by Estrogen in the Human Endometrium Requires Epidermal Growth Factor Signaling
- (2010) Hellen Dassen et al. AMERICAN JOURNAL OF PATHOLOGY
- Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis
- (2010) Phulwinder K. Grover et al. CANCER AND METASTASIS REVIEWS
- Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection
- (2010) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- OLFM4 Is a Robust Marker for Stem Cells in Human Intestine and Marks a Subset of Colorectal Cancer Cells
- (2009) Laurens G. van der Flier et al. GASTROENTEROLOGY
- Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients
- (2009) Naohide Oue et al. INTERNATIONAL JOURNAL OF CANCER
- The regulation ofOLFM4expression in myeloid precursor cells relies on NF-κB transcription factor
- (2008) Kyung L. Chin et al. BRITISH JOURNAL OF HAEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More